BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 34478876)

  • 21. Long noncoding RNA ZFPM2-AS1 acts as a miRNA sponge and promotes cell invasion through regulation of miR-139/GDF10 in hepatocellular carcinoma.
    He H; Wang Y; Ye P; Yi D; Cheng Y; Tang H; Zhu Z; Wang X; Jin S
    J Exp Clin Cancer Res; 2020 Aug; 39(1):159. PubMed ID: 32795316
    [TBL] [Abstract][Full Text] [Related]  

  • 22. lncRNA MALAT1 modulates cancer stem cell properties of liver cancer cells by regulating YAP1 expression via miR‑375 sponging.
    Zhao L; Lou G; Li A; Liu Y
    Mol Med Rep; 2020 Aug; 22(2):1449-1457. PubMed ID: 32626943
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Downregulation of lncRNA SBF2-AS1 inhibits hepatocellular carcinoma proliferation and migration by regulating the miR-361-5p/TGF-β1 signaling pathway.
    Wu YH; Yu B; Chen WX; Ai X; Zhang W; Dong W; Shao YJ
    Aging (Albany NY); 2021 Aug; 13(15):19260-19271. PubMed ID: 34341185
    [TBL] [Abstract][Full Text] [Related]  

  • 24. LncRNA DARS-AS1 aggravates the growth and metastasis of hepatocellular carcinoma via regulating the miR-3200-5p-Cytoskeleton associated protein 2 (CKAP2) axis.
    Feng Y; Wei G; Zhang L; Zhou H; Wang W; Guo P; Cheng C; Ji L; Cai Q; Feng Y; Tu H
    Bioengineered; 2021 Dec; 12(1):8217-8232. PubMed ID: 34596006
    [TBL] [Abstract][Full Text] [Related]  

  • 25. OGDHL silencing promotes hepatocellular carcinoma by reprogramming glutamine metabolism.
    Dai W; Xu L; Yu X; Zhang G; Guo H; Liu H; Song G; Weng S; Dong L; Zhu J; Liu T; Guo C; Shen X
    J Hepatol; 2020 May; 72(5):909-923. PubMed ID: 31899205
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Long non-coding RNA MALAT-1 overexpression predicts tumor recurrence of hepatocellular carcinoma after liver transplantation.
    Lai MC; Yang Z; Zhou L; Zhu QQ; Xie HY; Zhang F; Wu LM; Chen LM; Zheng SS
    Med Oncol; 2012 Sep; 29(3):1810-6. PubMed ID: 21678027
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A novel lncRNA MCM3AP-AS1 promotes the growth of hepatocellular carcinoma by targeting miR-194-5p/FOXA1 axis.
    Wang Y; Yang L; Chen T; Liu X; Guo Y; Zhu Q; Tong X; Yang W; Xu Q; Huang D; Tu K
    Mol Cancer; 2019 Feb; 18(1):28. PubMed ID: 30782188
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Identification of potential transcription factors, long noncoding RNAs, and microRNAs associated with hepatocellular carcinoma.
    Yan H; Wang Q; Shen Q; Li Z; Tian J; Jiang Q; Gao L
    J Cancer Res Ther; 2018 Sep; 14(Supplement):S622-S627. PubMed ID: 30249878
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The long noncoding RNA OTUD6B-AS1 enhances cell proliferation and the invasion of hepatocellular carcinoma cells through modulating GSKIP/Wnt/β-catenin signalling via the sequestration of miR-664b-3p.
    Kong S; Xue H; Li Y; Li P; Ma F; Liu M; Li W
    Exp Cell Res; 2020 Oct; 395(1):112180. PubMed ID: 32682012
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Long non-coding RNA MALAT1 promotes angiogenesis and immunosuppressive properties of HCC cells by sponging miR-140.
    Hou ZH; Xu XW; Fu XY; Zhou LD; Liu SP; Tan DM
    Am J Physiol Cell Physiol; 2020 Mar; 318(3):C649-C663. PubMed ID: 31693399
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Long noncoding RNA SPRY4-IT1 promotes proliferation and metastasis of hepatocellular carcinoma via mediating TNF signaling pathway.
    Ma W; Chen X; Wu X; Li J; Mei C; Jing W; Teng L; Tu H; Jiang X; Wang G; Chen Y; Wang K; Wang H; Wei Y; Liu Z; Yuan Y
    J Cell Physiol; 2020 Nov; 235(11):7849-7862. PubMed ID: 31943198
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Knockdown of Long Noncoding RNA (lncRNA) Metastasis-Associated Lung Adenocarcinoma Transcript 1 (MALAT1) Inhibits Proliferation, Migration, and Invasion and Promotes Apoptosis by Targeting miR-124 in Retinoblastoma.
    Liu S; Yan G; Zhang J; Yu L
    Oncol Res; 2018 May; 26(4):581-591. PubMed ID: 28550678
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Quantitative proteomics reveals that long non-coding RNA MALAT1 interacts with DBC1 to regulate p53 acetylation.
    Chen R; Liu Y; Zhuang H; Yang B; Hei K; Xiao M; Hou C; Gao H; Zhang X; Jia C; Li L; Li Y; Zhang N
    Nucleic Acids Res; 2017 Sep; 45(17):9947-9959. PubMed ID: 28973437
    [TBL] [Abstract][Full Text] [Related]  

  • 34. lncRNA MIAT promotes proliferation and invasion of HCC cells via sponging miR-214.
    Huang X; Gao Y; Qin J; Lu S
    Am J Physiol Gastrointest Liver Physiol; 2018 May; 314(5):G559-G565. PubMed ID: 29097358
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Long Noncoding RNA MALAT1 Promotes Hepatocellular Carcinoma Development by SRSF1 Upregulation and mTOR Activation.
    Malakar P; Shilo A; Mogilevsky A; Stein I; Pikarsky E; Nevo Y; Benyamini H; Elgavish S; Zong X; Prasanth KV; Karni R
    Cancer Res; 2017 Mar; 77(5):1155-1167. PubMed ID: 27993818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Long noncoding RNA CPS1-IT1 suppresses the metastasis of hepatocellular carcinoma by regulating HIF-1α activity and inhibiting epithelial-mesenchymal transition.
    Wang TH; Yu CC; Lin YS; Chen TC; Yeh CT; Liang KH; Shieh TM; Chen CY; Hsueh C
    Oncotarget; 2016 Jul; 7(28):43588-43603. PubMed ID: 27248828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long noncoding RNA LINC02580 suppresses the invasion-metastasis cascade in hepatocellular carcinoma by targeting SRSF1.
    Xu L; Wang Z; Yin C; Pan F; Shi T; Tian Y
    Biochem Biophys Res Commun; 2020 Dec; 533(4):685-691. PubMed ID: 33168192
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Multiomics Integration Reveals the Landscape of Prometastasis Metabolism in Hepatocellular Carcinoma.
    Li Y; Zhuang H; Zhang X; Li Y; Liu Y; Yi X; Qin G; Wei W; Chen R
    Mol Cell Proteomics; 2018 Apr; 17(4):607-618. PubMed ID: 29371291
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Long noncoding RNA DUXAP8 contributes to the progression of hepatocellular carcinoma via regulating miR-422a/PDK2 axis.
    Wei F; Yang L; Jiang D; Pan M; Tang G; Huang M; Zhang J
    Cancer Med; 2020 Apr; 9(7):2480-2490. PubMed ID: 32022476
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Targeting ODC1 inhibits tumor growth through reduction of lipid metabolism in human hepatocellular carcinoma.
    Choi Y; Oh ST; Won MA; Choi KM; Ko MJ; Seo D; Jeon TW; Baik IH; Ye SK; Park KU; Park IC; Jang BC; Seo JY; Lee YH
    Biochem Biophys Res Commun; 2016 Sep; 478(4):1674-81. PubMed ID: 27592554
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.